内镜下膜剖析用于pyloric瘤的有效性和安全性
Shao-Bin Luo1,2, Zu-Qiang Liu1,2, Li Wang1,2,3
1Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Surgical endoscopy
|September 16, 2025
概括
内镜下粘膜切割 (ESD) 是对胆囊瘤的安全有效治疗方法. 这种微创手术显示出较低的并发症率和通过内镜气球扩张 (EBD) 成功管理ESD后的胆囊狭窄症.
科学领域:
- 胃肠病学 胃肠病学
- 内視鏡外科手術 內視鏡外科手術
- 在瘤学瘤学.
背景情况:
- 内镜切除是pyloric病变的标准,但内镜下粘膜切除 (ESD) 提出了技术上的挑战.
- 螺旋性瘤需要有效和安全的治疗选择.
研究的目的:
- 评估ESD在治疗甲状腺瘤的疗效和安全性.
- 评估并发症的管理,特别是ESD后的胆囊狭窄症.
主要方法:
- 在2011年6月至2024年8月期间,对103名为pyloric瘤接受ESD的患者进行了回顾性分析.
- 收集的数据包括患者人口统计,程序结果和后续结果.
主要成果:
- 在103个病变 (36个前皮洛里,49个皮洛里,18个后皮洛里) 上进行了ESD.
- 后皮洛里病变的手术时间更长,阻断切除率更低.
- 并发症包括延迟出血 (2名患者) 和ESD后的胆囊狭窄症 (5名患者),所有这些都通过内镜气球扩张 (EBD) 成功管理. 发现了一次复发.
结论:
- 内镜下粘膜切割 (ESD) 是可行的和安全的治疗选择,用于pyloric瘤.
- 透视气球扩张 (EBD) 是一种安全有效的治疗方法,用于治疗ESD后的胆道狭窄症.
相关概念视频
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
830
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
830
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
541
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
541
01:26Peptic Ulcer Disease IV: Management
439
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
439
01:29Endoscopic Procedures I: Esophagogastroduodenoscopy
935
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
935
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K